Côme Lepage

机构：Inserm, Université de Bourgogne, CHU Dijon Bourgogne, Fédération Francophone de Cancérologie Digestive, Maison des Sciences sociales et des Humanités de Dijon · ORCID：0000-0001-9211-4707

发表论文 375 篇 · 总被引 9603 次 · h-index 52

代表论文

Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) (2024 · European Journal of Cancer · 被引 29)
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR) (2024 · Digestive and Liver Disease · 被引 22)
Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial (2025 · Journal of Clinical Oncology · 被引 21)
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (2024 · JAMA Oncology · 被引 14)
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma (2025 · Communications Medicine · 被引 13)
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials (2025 · Journal of Clinical Oncology · 被引 12)